Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Other Neutral

Canadian Securities Exchange Reports March 2026 Performance Figures

UberDoc Health Technologies Corp.

By The Northwire Desk — AI Analysis Apr 17, 2026 · 13:50 APPT · 0.36 UBERDOC Health Technologies Corp.
Executive Summary
  • The most recent release (April 17, 2026) is a Canadian Securities Exchange (CSE) monthly performance report highlighting trading volume and new listings.
  • UberDoc (APPT) is listed among six new issuers for March 2026, confirming its presence on the exchange but providing no specific operational updates.
  • Previous news (April 14, 2026) details Dr. Paula Muto's appointment to a U.S. Federal Health Advisory Committee (NCVHS), enhancing regulatory credibility.
  • Historical context includes listings on CSE (March 18) and Frankfurt Stock Exchange (March 24) via Reverse Takeover of ROV Investment Partners Corp.
  • Management plans include an OTCQB listing in the U.S. for Q2 2026 to broaden investor access.
Material Impact
  • The most recent CSE report is neutral regarding UberDoc's specific valuation as it aggregates exchange-wide data rather than company-specific fundamentals.
  • The April 14 appointment of Dr. Muto is positive for credibility but does not translate to immediate revenue or earnings, classifying it as incremental rather than material.
  • Stock price declined from $0.40 (March 18) to $0.36 (April 16), indicating the market has not priced in the Frankfurt listing or federal appointment positively yet.
  • Lack of financial statements prevents assessment of whether the reverse takeover carried hidden liabilities or debt obligations.
  • No evidence of capital raises in the provided news suggests current liquidity is sufficient for operations but growth plans may require future financing.
APPT · Price
Company Overview
  • UberDoc operates a two-sided direct-pay marketplace connecting patients with board-certified specialists across 55 U.S. specialties.
  • Platform features include AI-guided symptom matching, transparent upfront pricing, and bypassing insurance/referral barriers.
  • Flagship Project: The digital healthcare platform currently serving over 5,000 physicians in the U.S.
  • Business Model relies on direct patient payments rather than traditional insurance billing to reduce administrative complexity.
Read the original news release →

More from UBERDOC Health Technologies Corp.

Jun 30, 2026 · 08:01

Direct-pay specialist marketplace expands network via Emphera Health partnership to bypass insurance gatekeeping.

M&A / Property May 15, 2026 · 20:01

Founder takes interim CEO role after abrupt exit of public-market shepherd; early-stage credibility in question.

Management Apr 30, 2026 · 08:00

UberDoc AI Partnership Validates Strategy But Liquidity and Revenue Visibility Remain Key Risks

M&A / Property Apr 14, 2026 · 01:01

Direct-pay specialist care marketplace connecting patients with physicians

Management Mar 24, 2026 · 08:31

UberDoc Health Technologies Corp. Announces Listing on the Frankfurt Stock Exchange

Regulatory Mar 18, 2026 · 09:39

UBERDOC Health Technologies Corp. to Begin Trading on the Canadian Securities Exchange Under the Symbol "APPT"

Regulatory